Shcherbakov et al., 2011 - Google Patents
Nanocrystalline ceria based materials—Perspectives for biomedical applicationShcherbakov et al., 2011
View PDF- Document ID
- 18380824232369415002
- Author
- Shcherbakov A
- Ivanov V
- Zholobak N
- Ivanova O
- Krysanov E
- Baranchikov A
- Spivak N
- Tretyakov Y
- Publication year
- Publication venue
- Biophysics
External Links
Snippet
Nanocrystalline ceria possesses a unique complex of physical and chemical properties making it highly bioactive material. In this review, modern data on the action of nanocrystalline ceria on cells, micro-and macroorganisms are analyzed. Special attention is …
- OFJATJUUUCAKMK-UHFFFAOYSA-N Cerium(IV) oxide [O-2]=[Ce+4]=[O-2] 0 title abstract description 141
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
- A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
- A61K47/48769—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form
- A61K47/48853—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form the form being a particulate, powder, adsorbate, bead, sphere
- A61K47/48861—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form the form being a particulate, powder, adsorbate, bead, sphere the form being an inorganic particle, e.g. a ceramic particle, silica particle, ferrite, synsorb
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
- A61K31/285—Arsenic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
- A61K47/30—Macromolecular compounds
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin, zein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation; Therapies using these preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Shcherbakov et al. | Nanocrystalline ceria based materials—Perspectives for biomedical application | |
Shcherbakov et al. | Biological, biomedical and pharmaceutical applications of cerium oxide | |
Pachaiappan et al. | Metal/metal oxide nanocomposites for bactericidal effect: A review | |
Ivanov et al. | Structure-sensitive properties and biomedical applications of nanodispersed cerium dioxide | |
Sun et al. | Zinc oxide nanoparticle as a novel class of antifungal agents: current advances and future perspectives | |
Zhang et al. | Near infrared light-triggered metal ion and photodynamic therapy based on AgNPs/porphyrinic MOFs for tumors and pathogens elimination | |
Wang et al. | Nanozyme-based medicine for enzymatic therapy: progress and challenges | |
Panyala et al. | Silver or silver nanoparticles: a hazardous threat to the environment and human health? | |
Estes et al. | Characterization of a nitric oxide (NO) donor molecule and cerium oxide nanoparticle (CNP) interactions and their synergistic antimicrobial potential for biomedical applications | |
Kaur et al. | Combating drug-resistant bacteria using photothermally active nanomaterials: a perspective review | |
Bedi et al. | An overview on uses of zinc oxide nanoparticles | |
Gu et al. | Vitamin B 2 functionalized iron oxide nanozymes for mouth ulcer healing | |
Tian et al. | Rational design and biological application of antioxidant nanozymes | |
Li et al. | Nanozymes regulate redox homeostasis in ROS-related inflammation | |
Sharpe et al. | Artificial nanoparticle antioxidants | |
Liao et al. | Molybdenum-based antimicrobial nanomaterials: A comprehensive review | |
Hu et al. | Zinc oxide nanoparticles (ZnO NPs) combined with cisplatin and gemcitabine inhibits tumor activity of NSCLC cells | |
Cheng et al. | Multifunctional nanozyme hydrogel with mucosal healing activity for single-dose ulcerative colitis therapy | |
Li et al. | Application of metal-based nanozymes in inflammatory disease: a review | |
Yang et al. | Self-adaptive antibiofilm effect and immune regulation by hollow Cu2MoS4 nanospheres for treatment of implant infections | |
Zhang et al. | Designing nanozymes for in vivo applications | |
CN115381944A (en) | Coordination polymer nano material with copper death and photodynamic combined starvation treatment function and preparation method and application thereof | |
Zhao et al. | Electron transfer-based antioxidant nanozymes: Emerging therapeutics for inflammatory diseases | |
CN111602672B (en) | Antibacterial nano material and preparation method and application thereof | |
Priyadarshi et al. | Sulfur quantum dots as sustainable materials for biomedical applications: Current trends and future perspectives |